Shares of spirits company Brown-Forman (BF.B) fell after the company reportedly rejected a $15 billion acquisition offer from U.S.-based Sazerac. The decision comes just weeks after discussions between Brown-Forman and France’s Pernod Ricard (PRNDY) also collapsed, raising questions about the company’s strategic direction. BF.B stock was down 1.01% on Tuesday and slipped another 0.038% in after-hours trading.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
For context, Brown-Forman is a U.S.-based spirits and wine company best known for brands like Jack Daniel’s whiskey and Woodford Reserve. Even though the company is publicly traded, a majority of its voting power is controlled by members of the Brown family, giving them significant influence over the company’s decisions. Meanwhile, Sazerac Company is a privately held U.S. spirits producer.
Brown-Forman Ends Acquisition Talks
Sazerac Company emerged as a potential buyer for Brown-Forman last month, after merger talks between Brown-Forman and Pernod Ricard ended in late April without an agreement. Sazerac, which owns more than 500 brands including Buffalo Trace whiskey and Fireball, is controlled by the Goldring family.
The two deals were structured in very different ways. According to a source cited by Reuters, Pernod Ricard proposed a mostly stock-based deal similar to a merger of equals, which would have allowed the Brown family to keep a meaningful ownership stake and some influence in the combined company.
In contrast, Sazerac Company offered a deal that relied more on cash and higher leverage, which would have effectively forced the Brown family to give up control. The Brown family reportedly favored a possible deal with Pernod Ricard over Sazerac’s offer. They viewed Pernod as a more prestigious buyer because of its stronger and more globally recognized brand portfolio.
What this Means for Investors
The spirits industry is going through a prolonged slowdown, with weaker alcohol demand continuing to weigh on sales across the sector.
Nonetheless, the rejection of the Sazerac deal suggests that BF-B is not rushing into a sale and may be more focused on its long-term independent growth plan. It also reflects confidence from the controlling Brown family, even though it means shareholders lose out on a near-term takeover premium.
In the short term, the stock could remain volatile as investors adjust expectations around potential deals. Over the longer term, attention will likely return to business fundamentals such as sales performance, brand strength, and how the company handles the ongoing weakness in the spirits market.
Is BF.B Stock a Buy?
Across Wall Street, Brown-Forman’s shares have a Hold consensus based on one Buy, seven Holds, and three Sells assigned over the past three months. Moreover, the average BF.B price target of $27.25 implies an upside of 2.6% from the current level.
